Atlantic Union Bankshares’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7K Hold
1,350
﹤0.01% 962
2026
Q1
$40.7K Buy
1,350
+145
+12% +$4.67K ﹤0.01% 951
2025
Q4
$37.6K Hold
1,205
﹤0.01% 970
2025
Q3
$24.3K Buy
1,205
+705
+141% +$12.4K ﹤0.01% 1088
2025
Q2
$8.38K Buy
+500
New +$8.07K ﹤0.01% 940

Other funds holding TEVA

Atlantic Union Bankshares's TEVA Position: Q2 2026 in Review

Atlantic Union Bankshares held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 1,350 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #962.

Atlantic Union Bankshares first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Atlantic Union Bankshares held 1,350 shares of Teva Pharmaceuticals worth $45.7K as of Q2 2026.
  • Atlantic Union Bankshares left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #962 holding.
  • Atlantic Union Bankshares first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.